Aflatoxin B1 (AFB1) is a well-known carcinogen for human health, and requires sensitive and rapid methods for monitoring. Here, we developed an Avi-tagged nanobody (AviTag-Nb) and incorporated it into the biotin-streptavidin-amplified ELISA (BA-ELISA) and magnetic bead-based ELISA (MB-ELISA) to detect AFB1. After optimization, BA-ELISA and MB-ELISA achieved 50% inhibitory concentrations (IC50) of 0.28 and 0.53 ng/mL, respectively, and provided results within 50 and 26 min, making them more sensitive and time-saving compared to the classic ELISA. The detection limits (LODs) of BA-ELISA and MB-ELISA were down to 0.07 and 0.12 ng/mL, respectively, ensuring their practical application in AFB1 analysis. Additionally, both assays provided satisfactory recoveries (90.0%–97.2%) and favourable relative standard deviation (4.00–10.5%) when tested with spiked cereal samples, aligning well with the results obtained from HPLC. Therefore, the AviTag-Nb shows promise as a valuable reagent in immunoassays, and the proposed BA-ELISA and MB-ELISA methods can serve as practical analytical tools for determining AFB1 in real samples.
No takes yet. Share an insight, caveat, or question.
He et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: